Domaine de Maîtrise :
Biopathologie et Recherche Biomédicale

Domaine d’intérêt :
Biopathologie et Recherche Biomédicale**, Nouvelles Technologies - Ingénierie - Systèmes d’Information et IA

Les publications :
Barakat A, Ababou M, Onclercq R, Dutertre S, Chadli E, Hda N, Benslimane A, Amor-Guéret M. Identification of a novel BLM missense mutation(T2706C) in a moroccan patient with Bloom's syndrome.(2000). Human mutation 15:584-585. Foucault F, Vaury C, Barakat A, Thibout D, Planchon P, Jaulin C, Praz F, Amor-Gueret M. Caracterisation of a new BLM mutation associated with a topoisomerase IIæ defect in a patient with Bloom syndrome. (1997). Hum Mol Genet 6: 1427-1434. Amor-Guéret M, Dubois-d'Enghien C, Laugé A, Onclercq-Delic R, Barakat A, Chadli E, Bousfiha AA, Benjelloun M, Flori E, Doray B, Laugel V, Lourenço MT, Gonçalves R, Sousa S, Couturier J, Stoppa-Lyonnet D. Three new BLM gene mutations associated with Bloom syndrome (2008). Genet Test 12: 257-61. Abidi O, Knari S, Sefri H, Charif M, Senechal A, Hamel C, Rouba H, Zaghloul K, El Kettani A, Lenaers G, Barakat A. mutational analysis of the RB gene in Moroccan patients with retinoblastoma (2011). Mol Vis 17:3541-7. Hilmani S, Abidi O, Benrahma H, Karkouri M, Sahraoui S, El Azhari A, Barakat A. Clinicopathological Features and Molecular Analysis of Primary Glioblastomas in Moroccan Patients (2012). J Mol Neurosci. Aug 4. Senhaji MA, Abidi O, Nadifi S, Benchikhi H, Khadir K, Ben Rekaya M, Eloualid A, Messaoud O, Abdelhak S, Barakat A. c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum. Arch Dermatol Res. 2012 Nov 11 Jeddane L, Ailal F, Dubois-d'Enghien C, Abidi O, Benhsaien I, Kili A, Chaouki S, Kriouile Y, El Hafidi N, Fadil H, Abilkassem R, Rada N, Bousfiha AA, Barakat A, Stoppa-Lyonnet D, Bellaoui H. Molecular defects in Moroccan patients with ataxia-telangiectasia. Neuromolecular Med. 2013 Jan 16. Whole Exome Sequencing allows the identification of two novel groups of Xeroderma pigmentosum in Tunisia, XP-D and XP-E: Impact on molecular diagnosis. Ben Rekaya M, Naouali C, Messaoud O, Jones M, Bouyacoub Y, Nagara M, Pippucci T, Jmel H, Chargui M, Jerbi M, Alibi M, Dallali H, Bashamboo A, McElreavey K, Romeo G, Barakat A, Zghal M, Yacoub-Youssef H, Abdelhak S. J Dermatol Sci. 2017 Nov 2. pii: S0923-1811(16)30790-3 Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile. Kindil Z, Senhaji MA, Bakhchane A, Charoute H, Chihab S, Nadifi S, Barakat A. BMC Res Notes. 2017 Dec 6;10(1):704.